3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole as an anti-cancer and antimicrobial compound
A 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound, its synthesis, and its use as an antimicrobial agent.
1. A 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound having the formula I:
2. The 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 1 , wherein the compound is obtained as crystals.
3. The 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 1 , wherein the compound has a melting point of about 172° C. to about 173° C.
4. A pharmaceutically acceptable composition comprising a therapeutically effective amount of the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 1 and a pharmaceutically acceptable carrier.
5. A method of treating a microbial infection in a patient comprising administering to a patient in need thereof a therapeutically effective amount of the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 1 .
6. The method of treating the microbial infection of claim 5 , wherein the microbial infection is caused by one or more bacteria or fungi.
7. The method of treating the microbial infection of claim 5 , wherein the microbial infection is caused by one or more gram positive bacteria, one or more gram negative bacteria, one or more fungi, or a combination thereof.
8. The method of treating the microbial infection of claim 6 , wherein the one or more gram positive bacteria are Bacillus cereus, Staphylococcus aureus , or a combination thereof.
9. The method of treating the microbial infection of claim 6 , wherein the one or more gram negative bacteria are Pseudomonas aeruginosa, Escherichia coli , or a combination thereof.
10. The method of treating the microbial infection of claim 6 , wherein the one or more fungi are Aspergillus flavus, Chrysosporium keratinophilum , or a combination thereof.
11. A method of treating cancer in a patient comprising administering to a patient in need thereof a therapeutically effective amount of the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 1 .
12. The method of treating cancer of claim 11 , wherein the cancer is one or more selected from the group consisting of leukemia, melanoma, colon cancer, prostate cancer, lung cancer, pancreatic cancer, osteosarcoma, and breast cancer.
13. The method of treating cancer of claim 11 , wherein the cancer is prostate cancer or osteosarcoma.
14. A method of making the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 1 , the method comprising:
adding carbonyldiimidazole (CDI) to a solution of [5-methyl-2-(propan-2-yl)phenoxy]acetic acid in acetonitrile to obtain a first reaction mixture;
stirring the first reaction mixture;
adding 4-nitro-N′-hydroxybenzene-1-carboximidamide to the first reaction mixture to obtain a second reaction mixture;
stirring the second reaction mixture;
purifying a formed precipitate by filtering and recrystallization from acetonitrile; and
obtaining the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound.
15. The method of making the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 14 , wherein the stirring the first reaction mixture lasts for at least about 40 minutes.
16. The method of making the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 14 , wherein the first reaction mixture is stirred at room temperature.
17. The method of making the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 14 , wherein the second reaction mixture is stirred for at least about 4 hours.
18. The method of making the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 14 , wherein the formed precipitate is washed with cold acetonitrile.
19. The method of making the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole of claim 14 , wherein the 4-nitro-N′-hydroxybenzene-1-carboximidamide and CDI are added in about a 1:1.1 molar ratio.
20. The method of making the 3-(4-nitrophenyl)-5-((2-isopropyl-5-methylphenoxy)methyl)-1,2,4-oxadiazole compound of claim 14 , wherein the 4-nitro-N′-hydroxybenzene-1-carboximidamide, CDI, and N′-hydroxybenzenecarboximidamide are added in about a 1:1.1:1 molar ratio.